Understanding The Metabolic Pathways Of Terbinafine In The Body

by

Terbinafine is an antifungal medication commonly used to treat fungal infections of the skin and nails. Understanding how it is metabolized in the body is essential for optimizing its efficacy and minimizing side effects. The metabolic pathways of terbinafine involve complex processes primarily occurring in the liver.

Overview of Terbinafine Metabolism

After oral administration, terbinafine is absorbed into the bloodstream and transported to the liver, where it undergoes extensive metabolism. The primary goal of these metabolic processes is to convert the drug into more water-soluble compounds for easier excretion via urine and feces.

Major Metabolic Pathways

1. N-Demethylation

This pathway involves the removal of a methyl group from the nitrogen atom in terbinafine’s structure. The enzyme primarily responsible is cytochrome P450 2C9 (CYP2C9). The resulting metabolite is less active but more water-soluble, facilitating elimination.

2. Aromatic Hydroxylation

In this process, hydroxyl groups are added to the aromatic rings of terbinafine by cytochrome P450 enzymes, mainly CYP1A2 and CYP3A4. This modification increases the polarity of the molecule, aiding in its excretion.

Metabolite Excretion

The metabolites formed through N-demethylation and aromatic hydroxylation are conjugated with glucuronic acid or sulfate groups. These conjugates are then excreted primarily via urine, with a smaller amount eliminated through feces.

Factors Influencing Metabolism

  • Genetics: Variations in cytochrome P450 enzymes can affect the rate of terbinafine metabolism.
  • Drug Interactions: Concomitant use of other medications that inhibit or induce CYP enzymes may alter terbinafine levels.
  • Age and Liver Function: Older age and impaired liver function can slow metabolism, affecting drug clearance.

Clinical Significance

Understanding terbinafine’s metabolic pathways helps clinicians optimize dosing, predict potential drug interactions, and manage side effects. It also guides the development of new formulations with improved pharmacokinetic profiles.